Skip to main content

Table 4 Literature review of mantle cell lymphoma

From: Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV status

Name

year

Number of Cases

Age/sex

Site of tongue

Clinical feature

Cytologic Features

Stage

Treatment

Survival

Saxman S, et al. [40]

1997

1

68/M

Right base

Mass, acute shortness of breath

–

II

CHOP and RT

Died after 18 months

Guastafierro S, et al. [17]

2008

1

62/F

right half

Mass, no symptom mentioned

small lymphocytes, with slightly irregular

indented nuclei and moderately dispersed chromatin

IEA

R-CEOP

Plus

Rituximab maintenance therapy

Free of disease for 4 years and 5 months

Owosho, et al. [27]

2014

1

60/F

Base of tongue

–

containing many

large cells similar to DLBCL

–

–

–

  1. F: female; M: male; CHOP: C-cyclophosphamide H-doxorubicin (hydroxydaunomycin) O-vincristine P- prednisolone; RT: radiation therapy; DLBCL: diffuse large B cell lymphoma; R-CEOP: Rituximab–Cyclophosphamide, Epirubicine, Vincristine, Prednisone; −: not mentioned
  2. Cyclophosphamide, Epirubicine, Vincristine, Prednisone; −: not mentioned